Legal & General Group
RUBY

Legal & General Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Legal & General Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,367
Closed -$79K – 3736
2022
Q1 		$79K Hold
14,367
– – ﹤0.01% 2923
2021
Q4 		$140K Buy
14,367
+107
+0.8% +$1.48K ﹤0.01% 2834
2021
Q3 		$255K Buy
14,260
+7,884
+124% +$171K ﹤0.01% 2608
2021
Q2 		$155K Buy
6,376
+1,629
+34% +$40.7K ﹤0.01% 2603
2021
Q1 		$126K Sell
4,747
-275
-5% -$4.02K ﹤0.01% 2557
2020
Q4 		$38K Hold
5,022
– – ﹤0.01% 2881
2020
Q3 		$25K Sell
5,022
-1,436
-22% -$7.61K ﹤0.01% 2918
2020
Q2 		$39K Sell
6,458
-1,063
-14% -$6.28K ﹤0.01% 2801
2020
Q1 		$33K Sell
7,521
-1,018
-12% -$7.56K ﹤0.01% 2736
2019
Q4 		$81K Buy
8,539
+1,317
+18% +$12.7K ﹤0.01% 2663
2019
Q3 		$57K Hold
7,222
– – ﹤0.01% 2695
2019
Q2 		$113K Buy
7,222
+1,607
+29% +$25.9K ﹤0.01% 2490
2019
Q1 		$102K Buy
5,615
+3,770
+204% +$57.9K ﹤0.01% 2478
2018
Q4 		$30K Hold
1,845
– – ﹤0.01% 2912
2018
Q3 		$44K Buy
+1,845
New +$42.2K ﹤0.01% 2846

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's RUBY Position: Q2 2022 in Review

Legal & General Group sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 14,367 shares — an estimated $79K sold.

Legal & General Group first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $255K in Q3 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Legal & General Group reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 14,367 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $79K.
  • Legal & General Group first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • Legal & General Group's Rubius Therapeutics, Inc position peaked at $255K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.